Jennifer Green
Endocrinology, Diabetes & Metabolism · Durham, NCNPI 1770674517
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $296,696 of the $438,605 with a category attached, or 67.6%. 18 manufacturers reported payments, led by Eli Lilly at 32.2% of the total. Among endocrinology, diabetes & metabolism clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $1041.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$141K
- Boehringer Ingelheim International GmbH$68K
- Boehringer Ingelheim$67K
- Novo Nordisk$57K
- Bayer$52K
- Vertex$25K
- plus $28K from 12 others
Across 7 payments — averaging $1223.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$4K
- Bayer$4K
- E.r. Squibb & Sons, L.L.C.$587
What the payments were for
- Consulting fees$296,69668%
- Speaking & faculty fees$42,78510%
- Travel & lodging$90,17921%
- Food & beverage$8,9452%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 130 | $141,059 |
| Boehringer Ingelheim International GmbH | 55 | $67,736 |
| Boehringer Ingelheim | 84 | $67,193 |
| Novo Nordisk | 34 | $57,138 |
| Bayer | 47 | $52,432 |
| Vertex | 24 | $25,325 |
| Novo Nordisk AS | 5 | $7,279 |
| Corcept Therapeutics | 4 | $6,133 |
| Idorsia Pharmaceuticals US Inc | 1 | $4,865 |
| Lilly USA, LLC | 6 | $4,413 |
| Astrazeneca UK Limited | 4 | $3,079 |
| Merck | 2 | $1,030 |
| AstraZeneca | 2 | $377 |
| Medtronic | 13 | $263 |
| Esperion Therapeutics, Inc. | 2 | $123 |
| Amgen | 3 | $67 |
| Tandem Diabetes Care, Inc. | 4 | $53 |
| Zealand Pharma A/s | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$438,605 in reported general payments places this provider in the 95th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
See all endocrinology, diabetes & metabolism providers in North Carolina →
Other endocrinology, diabetes & metabolism in Durham
- Todd FriezeDurham$421K
- David D AlessioDurham$212K
- Thomas WeberDurham$16K
- Leena ShahlaDurham$14K
- Mark WarrenGreenville$915K
- Thomas OconnellBurlington$805K
- Corey BerlinRaleigh$742K
- Michael FavoritoWilmington$723K
- Stephen SouthGreensboro$624K
- Richard DoddAsheville$526K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.